PHVS - Pharvaris N.V. Projected Sales Volume

Official company branding of Pharvaris (PHVS)

Cost optimization through the outsourcing of development and synthesis serves as the foundation for the growth of Pharvaris N.V. (PHVS), and the company's estimated sales level on the GURU.Markets daily chart confirms this trend, where the indicator value stands at 0.00. The brand's high authority in medicine and the uniqueness of its drugs for treating hereditary angioedema create a favorable environment, offsetting the risks associated with the business's narrow specialization.

Company Expected Revenue: Pharvaris Pharma (PHVS) for 07/04/2022 - 11/17/2026

Analytical breakdowns for Pharvaris N.V.

- stock value and consensus price forecast:
Fundamental valuation:Pharvaris PHVS
Brand item of Pharvaris Corp

This indicator assesses revenue potential by analyzing market demand and institutional capital dynamics to determine the business's financial survival threshold. By analyzing the expected trading volumes of Pharvaris N.V. (PHVS), an investor can identify the correlation between the cycle phase and volatility risk. For Pharvaris N.V. (PHVS), this metric is critical: growth in indicators is possible only after the removal of FDA restrictions, which currently block the inflow of investment into the edema therapy ecosystem.

Competing companies

Company Projected Revenue Argenx (ARGX)|BioNTech - Company Revenue Forecast|Projected Sales Volume ABVX (Abivax)|ADMA Bio (ADMA) - Company Expected Sales Volume|PTGX - Company Projected Revenue|Company Future Sales immunovant.com IMVT|KNSA: Projected Sales Volume|Grifols - Company Future Revenue|ADPT (Adaptive Biotech) - Projected Sales Volume|Company Projected Revenue CLDX|Projected Sales Volume AUPH|Company Future Sales Volume biocryst.com BCRX|Vera Therapeutics - Company Future Sales Volume|Company Projected Revenue Volume DNTH (Dianthus Therapeutics, Inc.)|ABCL - Company Projected Revenue|TRML - Projected Sales Volume|PGEN: Projected Sales Volume|Company Revenue Forecast PHAR|Company Future Sales Volume NKTR|UPB: Company Future Revenue|Company Projected Revenue zenasbio.com (ZBIO)|IMNM (Immunome Corp) - Company Future Revenue|Projected Sales Volume GOSS (Gossamer Bio, Inc.)|KALV (KalVista Pharmaceuticals) - Company Expected Revenue|SEPN - Company Projected Revenue|Company Future Revenue PVLA (Pieris Pharma)|Savara Pharma (SVRA) - Company Projected Revenue|Rigel Pharmaceuticals Inc (RIGL) - Projected Sales Volume|Company Projected Revenue AnaptysBio|Astria Therapeutics - Company Expected Revenue|Projected Sales Volume ENGN|Company Projected Revenue Volume RAPT|Company Projected Revenue Aerovate Therapeutics, Inc. JBIO|Aclaris Therapeutics (ACRS) - Company Expected Sales Volume|KYTX: Company Future Sales Volume|Company Future Sales Tiziana Life Sciences TLSA|CABA: Projected Sales Volume|Company Expected Sales Volume Ventyx Biosciences Inc. (VTYX)|Company Future Sales Volume THTX|Avalo Therapeutics, Inc (AVTX) - Company Future Sales|Projected Sales Volume ELDN|Company Future Sales Volume agenusbio.com AGEN|Projected Sales Volume CLYM (climbbio.com)|Projected Sales Volume Zura Bio Ltd ZURA|ATYR - Company Projected Revenue|Adagene Inc (ADAG) - Company Future Sales Volume|IMA: Projected Sales Volume|Shattuck Therapeutics (STTK) - Projected Sales Volume|Company Projected Revenue equilliumbio.com|CNTB: Company Future Revenue|Projected Sales Volume IMUX|ATRA (Atara Bio) - Company Future Revenue|Company Projected Revenue InflaRx N.V. IFRX|x4pharma.com - Company Projected Revenue|ACET - Company Projected Revenue|Company Future Revenue CELU (celularity.com)|INMB: Projected Sales Volume|Barinthus Biotherapeutics Corp - Company Future Revenue|Company Future Sales Volume KZR|Company Future Sales Volume SAB Biotherapeutics (SABS)|Company Future Sales Volume AKTX (Akari Therapeutics Plc)|Company Future Sales Volume Enlivex Therapeutics Ltd. ENLV|Q32 Bio Corp - Company Future Sales Volume|GOVX - Company Future Sales Volume|EDSA - Company Projected Revenue|Company Future Revenue IBIO (iBio, Inc.)|CARM: Projected Sales Volume|XTL Biopharmaceuticals, Ltd. (XTLB) - Projected Sales Volume|Company Projected Revenue boltbio.com|Projected Sales Volume hcwbiologics.com|Company Future Sales Volume APVO (aptevotherapeutics.com)|Company Future Sales AIM ImmunoTech, Inc.|Projected Sales Volume ADTX (Aditxt)|Company Future Revenue GRI|XRTX - Company Projected Revenue|HIND: Company Projected Revenue|REVB (Revelation Biosciences Corp) - Company Future Sales Volume|Company Revenue Forecast INDP|Company Projected Revenue Scinai Immunotherapeutics Ltd|calcimedica.com (CALI) - Company Future Sales|Company Projected Revenue Affimed NV (AFMD)|Allakos - Company Revenue Forecast|Company Projected Revenue HOOKIPA Pharma, Inc. HOOK|IGMS - Company Future Sales Volume|ITOS: Company Future Sales Volume|Company Expected Sales Volume Ocean Biomedical|TCBP: Projected Sales Volume|Third Harmonic Bio, Inc - Company Future Revenue